25-11-2025 17:37 via drugs.com

Discontinuing GLP-1 Receptor Agonist Use Before Pregnancy Tied to Risk for Adverse Outcomes

TUESDAY, Nov. 25, 2025-- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use with subsequent prepregnancy or early pregnancy discontinuation is associated with more gestational weight gain and a higher risk for preterm delivery, gestational...

Persistent Thyroid Hormone Imbalance During Pregnancy Tied to Heightened Autism Risk in Offspring

Eight Trajectories of Long COVID Identified in U.S. Adults

Less Than One in Five Who Are Eligible Undergo Lung Cancer Screening

Obstructive Sleep Apnea Appears to Be Risk Factor for Development of Parkinson Disease

Grant Funding Disruptions Affect One in 30 Clinical Trials

First-Trimester Ultrasounds Detect 40 Percent of Anomalies

Exome Sequencing Can ID Those Who Are Genotype-Positive for Familial Hypercholesterolemia

Early Use of Higher-Efficacy Therapies Recommended for Moderate-to-Severe Crohn Disease

Radiofrequency Coagulation Effective for Recurrent Anterior Epistaxis

Adenotonsillectomy Safe in Children With Down Syndrome, Other Genetic Syndromes

Cannabis Use Disorder Adversely Affects Inpatient Asthma Outcomes

U.S. Faces Continuing Maternal and Infant Health Crisis

Higher Blood Pressure in Teens Tied to Later Risk for Atherosclerosis

Smoking Cannabis Tied to Less Subsequent Alcohol Consumption

Desktop versie

Discontinuing GLP-1 Receptor Agonist Use Before Pregnancy Tied to Risk for Adverse Outcomes

Pharmaceutical Industry news